4//SEC Filing
Merck & Co., Inc. 4
Accession 0001225208-17-002443
$MRKCIK 0000310158operating
Filed
Feb 5, 7:00 PM ET
Accepted
Feb 6, 3:35 PM ET
Size
8.4 KB
Accession
0001225208-17-002443
Insider Transaction Report
Form 4
Cech Thomas R
Director
Transactions
- Exercise/Conversion
Common Stock
2017-02-03$35.19/sh+5,000$175,950→ 5,100 total - Sale
Common Stock
2017-02-03$63.42/sh−5,000$317,100→ 100 total - Exercise/Conversion
Stock Option (right to buy)
2017-02-03−5,000→ 0 totalExercise: $35.19From: 2011-08-04Exp: 2020-08-03→ Common Stock (5,000 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $63.3800 to $63.4562, inclusive. The reporting person undertakes to provide to Merck & Co., Inc., any security holder of Merck & Co., Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above in this footnote.
- [F2]The option became exercisable in equal installments on 8/4/2011, 8/4/2012 and 8/4/2013.
Documents
Issuer
Merck & Co., Inc.
CIK 0000310158
Entity typeoperating
IncorporatedNJ
Related Parties
1- filerCIK 0000310158
Filing Metadata
- Form type
- 4
- Filed
- Feb 5, 7:00 PM ET
- Accepted
- Feb 6, 3:35 PM ET
- Size
- 8.4 KB